id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0539-0024,FDA,FDA-2009-D-0539,Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products Guidance for Industry,Other,Guidance,2016-04-26T04:00:00Z,2016,4,2016-04-26T04:00:00Z,,2019-06-18T16:22:13Z,,0,0,0900006481f902a5
FDA-2009-D-0539-0023,FDA,FDA-2009-D-0539,Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products; Revised Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-04-25T04:00:00Z,2016,4,2016-04-25T04:00:00Z,2016-06-25T03:59:59Z,2016-06-25T13:00:11Z,2016-09449,0,0,0900006481f89040